Our Story

At Impax Laboratories we are following a growth-oriented strategy to become a leader in the development, manufacturing and marketing of specialty prescription pharmaceutical products.

Strategic Merger

On December 14, 1999, Global Pharmaceutical Corporation and privately held Impax Pharmaceuticals, Inc. completed a reverse merger, forming a new organization called Impax Laboratories, Inc. The merger combined the advanced drug delivery systems developed by Impax Pharmaceuticals through its research and development capabilities with Global Pharmaceutical’s sales, marketing and distribution capabilities.

New Drug Applications

The synergy created by the merger provided the foundation for the current and future success of the organization. Since 1999, the company has continued to increase sales of existing products, consistently filed abbreviated new drug applications with the Food and Drug Administration (FDA) annually, and has received tentative and final approval from the FDA for numerous products.

Marketing Partnerships

Where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform in order to maximize product revenues and profitability. Impax also has two marketing divisions of its own for its products. Its Global Pharmaceuticals division sells generic products, while branded products are marketed through the Impax Pharmaceuticals division.